Normal Glucose Tolerance and Gestational Diabetes Mellitus
Open Access
- 1 July 2007
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (7) , 1783-1788
- https://doi.org/10.2337/dc07-0119
Abstract
OBJECTIVE— The aim of this article was to define the metabolic phenotype of pregnant women with one abnormal value (OAV) during an oral glucose tolerance test (OGTT) and to test whether OAV could be considered metabolically comparable to gestational diabetes mellitus (GDM) or a specific entity between GDM and normal pregnancy. RESEARCH DESIGN AND METHODS— After 100-g 3-h OGTTs, 4,053 pregnant women were classified as having GDM, OAV, or normal glucose tolerance (NGT). Those with OAV were subdivided into three subgroups: fasting hyperglycemia (one abnormal value at fasting during an OGTT), 1-h hyperglycemia (one abnormal value at 1 h during an OGTT [1h-OAV]), or 2- or 3-h hyperglycemia (one abnormal value at 2 or 3 h during an OGTT). As derived from the OGTT, we measured insulin sensitivity (insulin sensitivity index [ISI] Matsuda) and insulin secretion (homeostasis model assessment for the estimation of β-cell secretion [HOMA-B], first- and second-phase insulin secretion). The product of the first-phase index and the ISI was calculated to obtain the insulin secretion–sensitivity index (ISSI). RESULTS— GDM was diagnosed in 17.9% and OAV in 18.7% of pregnant women; women with GDM and OAV were older and had higher BMI and serum triglyceride levels than those with NGT (all P < 0.05). Women with NGT had the highest ISI followed by those with OAV (−21.7%) and GDM (−32.1%). HOMA-B results were comparable with those for OAV and GDM but significantly (P < 0.01) lower than those for NGT; first- and second-phase insulin secretion appeared progressively reduced from that in women with NGT to that in women with OAV and GDM (P < 0.01). ISSI was higher in women with NGT than in women with either OAV (−34%) or GDM (−51.7%) (P < 0.001). Among OAV subgroups, the 1h-OAV subgroup showed the lowest ISSI (P < 0.05). CONCLUSIONS— OAV and GDM are clinically indistinguishable, and both groups are different from women with NGT. Women with GDM and OAV showed impaired insulin secretion and insulin sensitivity, although these defects are more pronounced in women with GDM. Compared with other OAV subgroups, 1h-OAV could be considered a more severe condition.Keywords
This publication has 26 references indexed in Scilit:
- Risk of Progression to Type 2 Diabetes Based on Relationship Between Postload Plasma Glucose and Fasting Plasma GlucoseDiabetes Care, 2006
- Women with one elevated 3-hour glucose tolerance test value: Are they at risk for adverse perinatal outcomes?American Journal of Obstetrics and Gynecology, 2006
- Impaired Glucose Tolerance of Pregnancy Is a Heterogeneous Metabolic Disorder as Defined by the Glycemic Response to the Oral Glucose Tolerance TestDiabetes Care, 2006
- Adiponectin and beta cell dysfunction in gestational diabetes: pathophysiological implicationsDiabetologia, 2005
- Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetesDiabetic Medicine, 2004
- Pancreatic B-Cell Defects in Gestational Diabetes: Implications for the Pathogenesis and Prevention of Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 2001
- Gestational Diabetes MellitusNew England Journal of Medicine, 1999
- Relationship between plasma glucose levels in glucose-intolerant women and newborn macrosomiaThe Journal of Maternal-Fetal Medicine, 1997
- Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetesAmerican Journal of Obstetrics and Gynecology, 1995
- Fetal Outcome in Mothers with Impaired Glucose Tolerance in PregnancyDiabetic Medicine, 1993